Allogeneic haematopoietic cell transplantation for chronic myelogenous leukaemia in the era of imatinib: a retrospective multicentre study-Reference-Cited by-同舟云学术

Allogeneic haematopoietic cell transplantation for chronic myelogenous leukaemia in the era of imatinib: a retrospective multicentre study

Published:2006-01 Issue:1 Volume:76 Page:9-17
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Bornhauser Martin,Kroger Nicolaus,Schwerdtfeger Rainer,Schafer-Eckart Karin,Sayer Herbert G.,Scheid Christoph,Stelljes Mattias,Kienast Joachim,Mundhenk Peter,Fruehauf Stefan,Kiehl Michael G.,Wandt Hannes,Theuser Catrin,Ehninger Gerhard,Zander Axel R.,

Publisher

Wiley

Subject

Hematology,General Medicine

Reference32 articles.

1. Chronic Myeloid Leukemia — Advances in Biology and New Approaches to Treatment

2. Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome

3. Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia

4. Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation

5. Outcome of transplantation of highly purified peripheral blood CD34+ cells with T-cell add-back compared with unmanipulated bone marrow or peripheral blood stem cells from HLA-identical sibling donors in patients with first chronic phase chronic myeloid leukemia

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Haematopoietic stem cell transplantation after reduced intensity conditioning in children and adolescents with chronic myeloid leukaemia: A prospective multicentre trial of the I‐BFM Study Group;British Journal of Haematology;2024-05-27

2. Comparable Outcomes of Pre- Versus Post-Tyrosine Kinase Inhibitor Era Treatment in Chronic Myeloid Leukemia: A Retrospective Cohort Study With Long-term Follow-up;Cell Transplantation;2023-01

3. Efficacy of allogeneic hematopoietic cell transplantation in patients with chronic phase CML resistant or intolerant to tyrosine kinase inhibitors;Hematology/Oncology and Stem Cell Therapy;2021-03

4. Taming of the Shrew - Overcoming Extramedullary Blast Crisis in the Era of the New Tyrosine Kinase Inhibitors;Acta Haematologica;2013

5. Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis;Bone Marrow Transplantation;2011-10-10